))
Breaking Barriers in Nanomedicine with Priya Kumthekar, MD
Manage episode 469341343 series 3592955
Content provided by Seth Zimmerman and International Institute for Nanotechnology at Northwestern University. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Seth Zimmerman and International Institute for Nanotechnology at Northwestern University or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
In this episode, Northwestern Medicine neuro-oncologist, Priya Kumthekar, MD, discusses her pioneering work in nanomedicine on an early clinical trial in individuals with the deadly brain cancer glioblastoma. The study showed an experimental spherical nucleic acid drug, developed by Northwestern University scientists, was able to penetrate the blood-brain barrier and trigger the death of tumor cells. This was the first time a nanotherapeutic has been shown to cross the blood-brain barrier. The study set a precedent at Northwestern University and has opened the door for similar studies and innovations to take place here.
13 episodes
Share
